Literature DB >> 29659917

Jumonji domain-containing protein family: the functions beyond lysine demethylation.

Yuan Meng1, Hongzhi Li2, Changwei Liu1, Li Zheng1, Binghui Shen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29659917      PMCID： PMC6455909          DOI： 10.1093/jmcb/mjy010

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN： 1759-4685            Impact factor:   6.216


× No keyword cloud information.
  9 in total

1.  JmjC-domain-containing proteins and histone demethylation.

Authors:  Robert J Klose; Eric M Kallin; Yi Zhang
Journal:  Nat Rev Genet       Date:  2006-09       Impact factor: 53.242

Review 2.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

3.  Clipping of arginine-methylated histone tails by JMJD5 and JMJD7.

Authors:  Haolin Liu; Chao Wang; Schuyler Lee; Yu Deng; Matthew Wither; Sangphil Oh; Fangkun Ning; Carissa Dege; Qianqian Zhang; Xinjian Liu; Aaron M Johnson; Jianye Zang; Zhongzhou Chen; Ralf Janknecht; Kirk Hansen; Philippa Marrack; Chuan-Yuan Li; John W Kappler; James Hagman; Gongyi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

4.  Crystal structure of the 2-oxoglutarate- and Fe(II)-dependent lysyl hydroxylase JMJD6.

Authors:  Monica Mantri; Tobias Krojer; Eleanor A Bagg; Celia J Webby; Danica S Butler; Grazyna Kochan; Kathryn L Kavanagh; Udo Oppermann; Michael A McDonough; Christopher J Schofield
Journal:  J Mol Biol       Date:  2010-08-13       Impact factor: 5.469

Review 5.  Protein arginine methyltransferases and cancer.

Authors:  Yanzhong Yang; Mark T Bedford
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

6.  JMJD6 is a histone arginine demethylase.

Authors:  Bingsheng Chang; Yue Chen; Yingming Zhao; Richard K Bruick
Journal:  Science       Date:  2007-10-19       Impact factor: 47.728

7.  JMJD5 cleaves monomethylated histone H3 N-tail under DNA damaging stress.

Authors:  Jing Shen; Xueping Xiang; Lihan Chen; Haiyi Wang; Li Wu; Yanyun Sun; Li Ma; Xiuting Gu; Hong Liu; Lishun Wang; Ying-Nian Yu; Jimin Shao; Chao Huang; Y Eugene Chin
Journal:  EMBO Rep       Date:  2017-10-05       Impact factor: 8.807

8.  Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.

Authors:  Celia J Webby; Alexander Wolf; Natalia Gromak; Mathias Dreger; Holger Kramer; Benedikt Kessler; Michael L Nielsen; Corinna Schmitz; Danica S Butler; John R Yates; Claire M Delahunty; Phillip Hahn; Andreas Lengeling; Matthias Mann; Nicholas J Proudfoot; Christopher J Schofield; Angelika Böttger
Journal:  Science       Date:  2009-07-03       Impact factor: 47.728

9.  Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases.

Authors:  Louise J Walport; Richard J Hopkinson; Rasheduzzaman Chowdhury; Rachel Schiller; Wei Ge; Akane Kawamura; Christopher J Schofield
Journal:  Nat Commun       Date:  2016-06-23       Impact factor: 14.919
  9 in total
  6 in total

Review 1.  The Functions of the Demethylase JMJD3 in Cancer.

Authors:  Anna Sanchez; Fatma Zohra Houfaf Khoufaf; Mouhamed Idrissou; Frédérique Penault-Llorca; Yves-Jean Bignon; Laurent Guy; Dominique Bernard-Gallon
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

2.  JMJD6 negatively regulates cytosolic RNA induced antiviral signaling by recruiting RNF5 to promote activated IRF3 K48 ubiquitination.

Authors:  Wei Zhang; Qi Wang; Fan Yang; Zixiang Zhu; Yueyue Duan; Yang Yang; Weijun Cao; Keshan Zhang; Junwu Ma; Xiangtao Liu; Haixue Zheng
Journal:  PLoS Pathog       Date:  2021-03-08       Impact factor: 6.823

Review 3.  JMJD family proteins in cancer and inflammation.

Authors:  Wang Manni; Xue Jianxin; Hong Weiqi; Chen Siyuan; Shi Huashan
Journal:  Signal Transduct Target Ther       Date:  2022-09-01

Review 4.  Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.

Authors:  Navid Koleini; Jason S Shapiro; Justin Geier; Hossein Ardehali
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

Review 5.  Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension.

Authors:  Linh Ho; Nazir Hossen; Trieu Nguyen; Au Vo; Fakhrul Ahsan
Journal:  Biomedicines       Date:  2022-01-13

Review 6.  Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets.

Authors:  Carla S S Teixeira; Sérgio F Sousa
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.